| Structure | Chemical Name | CAS | MF |
|
1,2-Cyclohexanediol, 4-(2R)-oxiranyl-, (1R,2R,4S)- (9CI)
|
492458-54-5
|
C8H14O3
|
|
1,2-Cyclohexanediol, 4-(2S)-oxiranyl-, (1R,2R,4S)- (9CI)
|
492458-55-6
|
C8H14O3
|
|
1,2-Cyclohexanediol, 4-(2R)-oxiranyl-, (1S,2S,4R)- (9CI)
|
492458-56-7
|
C8H14O3
|
|
4-AMino-1-(tert-butoxycarbonyl)pyrrolidine-3-carboxylic acid
|
492461-79-7
|
C10H18N2O4
|
|
cis-4-Amino-1-Boc-pyrrolidine-3-carboxylic acid
|
492462-02-9
|
C10H18N2O4
|
|
alpha-D-Talopyranose, 2,3-di-C-methyl-3-O-methyl- (9CI)
|
492462-53-0
|
C9H18O6
|
|
9H-Purine,6-ethoxy-9-ethyl-8-methyl-(9CI)
|
492464-38-7
|
C10H14N4O
|
|
9H-Purine,6-ethoxy-8-methyl-9-propyl-(9CI)
|
492464-39-8
|
C11H16N4O
|
|
Methyl 2-methyl-2-propenoate polymer with ethenylbenzene, 2-ethylhexyl 2-propenoate, (1-methylethenyl)benzene and 2-propenoic acid, ammonium salt
|
492467-53-5
|
C36H50O6
|
|
ethyl (1R,2R)-2-cyanocyclopropane-1-carboxylate
|
492468-13-0
|
C7H9NO2
|
|
Cyclopropanecarboxylic acid, 2-propyl-, ethyl ester, (1R,2R)- (9CI)
|
492468-15-2
|
C9H16O2
|
|
ethyl (1R,2S)-2-cyanocyclopropane-1-carboxylate
|
492468-16-3
|
C7H9NO2
|
|
Cyclopropanecarboxylic acid, 2-ethoxy-, ethyl ester, (1R,2S)- (9CI)
|
492468-17-4
|
C8H14O3
|
|
Cyclopropanecarboxylic acid, 2-propyl-, ethyl ester, (1R,2S)- (9CI)
|
492468-18-5
|
C9H16O2
|
|
8-Methoxy-5-iodo-[1,2,4]triazolo[1,5-a]pyridin-2-yl-amine
|
492468-97-0
|
C7H7IN4O
|
|
1,2,4-Benzotriazine,7-fluoro-,1-oxide(9CI)
|
492469-53-1
|
C7H4FN3O
|
|
Bone morphogenetic protein receptor type-1A
|
492990-36-0
|
|
|
1H-Pyrazole-1-carboxylicacid,3,5-dimethyl-(9CI)
|
492998-68-2
|
C6H8N2O2
|
|
Bicyclo[3.2.1]octane-2,8-diol, 2,6-dimethyl-3-methylene-1-(2-propenyl)-, (1R,2R,5S,6R,8S)-rel- (9CI)
|
492999-17-4
|
C14H22O2
|
|
Ethyl 4-(2,6-difluorophenyl)-4-oxobutyrate
|
493004-53-8
|
C12H12F2O3
|
|
Piperidine, 1-acetyl-2-(2-propenyl)- (9CI)
|
493009-86-2
|
C10H17NO
|
|
Pinolenic Acid ethyl ester
|
493015-74-0
|
C20H34O2
|
|
beta-D-Galactopyranose, 3,4-anhydro-6-deoxy- (9CI)
|
493016-62-9
|
C6H10O4
|
|
alpha-D-arabino-Hexopyranoside, methyl 2-amino-2,4-dideoxy- (9CI)
|
493019-23-1
|
C7H15NO4
|
|
4-Isoxazolemethanol,3-(trifluoromethyl)-(9CI)
|
493019-55-9
|
C5H4F3NO2
|
|
2-Quinolin-4-yl-1-(4-trifluoromethylphenyl)ethanol
|
493024-38-7
|
C18H14F3NO
|
|
3-Chloro-5-fluorobenzyl bromide
|
493024-39-8
|
C7H5BrClF
|
|
Methyl 3-(aminomethyl)benzoate hydrochloride
|
493024-40-1
|
C13H14FN3O
|
|
(1-Benzyl-4-hydroxymethylpiperidin-4-ylmethyl)carbamic acid tert-butyl ester
|
493026-45-2
|
C19H30N2O3
|
|
CarbaMic acid, [[4-(hydroxyMethyl)-4-piperidinyl]Methyl]-, 1,1-diMethylethyl ester (9CI)
|
493026-47-4
|
C12H24N2O3
|
|
5-Ethyl-4-(4-methoxy-phenyl)-thiazol-2-ylamine
|
493028-20-9
|
C12H14N2OS
|
|
6-{[4-(Dimethylamino)phenyl]sulfanyl}-2-phenyl-5-(trifluoromethyl)pyrimidin-4-ol
|
493030-76-5
|
C19H16F3N3OS
|
|
3-(2,5-Dimethoxyphenyl)benzaldehyde
|
493030-93-6
|
C15H14O3
|
|
4-(2,4-Bis(trifluoromethyl)phenyl)benzaldehyde
|
493031-00-8
|
C13H8Br2O
|
|
(4-Hydroxy-2-methyl)phenylboronic acid
|
493035-82-8
|
C7H9BO3
|
|
1H-Pyrazole-4-carboxylicacid,1-(2-aminoethyl)-(9CI)
|
493036-32-1
|
C6H9N3O2
|
|
Piperidine, 4-isocyanato-1-(trifluoroacetyl)- (9CI)
|
493036-44-5
|
C8H9F3N2O2
|
|
2-(3,5-Difluorophenyl)malondialdehyde
|
493036-46-7
|
C9H6F2O2
|
|
2-(4-Fluorophenyl)malondialdehyde
|
493036-47-8
|
C9H7FO2
|
|
2-(4-Trifluoromethoxyphenyl)malondialdehyde
|
493036-48-9
|
C10H7F3O3
|
|
2-(3-Trifluoromethylphenyl)malondialdehyde
|
493036-49-0
|
C10H7F3O2
|
|
2-(4-Trifluoromethylphenyl)malondialdehyde
|
493036-50-3
|
C10H7F3O2
|
|
5-(chloromethyl)-3-phenyl-1H-pyrazole hydrochloride
|
493038-58-7
|
C10H10Cl2N2
|
|
2-Pyridineacetaldehyde,alpha-(hydroxymethylene)-,(alphaZ)-(9CI)
|
493038-78-1
|
C8H7NO2
|
|
4-Pyridineacetaldehyde,alpha-(hydroxymethylene)-,(alphaZ)-(9CI)
|
493038-82-7
|
C8H7NO2
|
|
3-(Dimethylamino)-2-(2-pyridinyl)acrylonitrile
|
493038-85-0
|
C10H11N3
|
|
4-Pyridin-2-yl-2H-pyrazol-3-ylamine
|
493038-87-2
|
C8H8N4
|
|
2,3-Dibromobenzotrifluoride
|
493038-92-9
|
C7H3Br2F3
|
|
3-Chloro-5-fluorophenylacetonitrile
|
493038-93-0
|
C8H5ClFN
|
|
1-benzyl-4-methylpiperidin-3-ol 4-methylbenzenesulfonate
|
493040-20-3
|
|
|
2-Pyridinemethanol,4-(dimethylamino)-alpha-methyl-(9CI)
|
494190-96-4
|
C9H14N2O
|
|
5-(4-Bromo-phenyl)-4-methyl-4 H-[1,2,4]triazole-3-thiol
|
494194-50-2
|
C9H8BrN3S
|
|
Pyrimidine, 2,4-dibromo-5-methyl- (9CI)
|
494194-61-5
|
C5H4Br2N2
|
|
(1S,5S,6R)-5-(Acetyloxy)-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic Acid Methyl Ester
|
494195-98-1
|
C10H12O5
|
|
Nickel, bis[N-[6-[2-(4,5-dicyano-1-methyl-1H-imidazol-2-yl-kN3)diazenyl-kN1]-1,2,3,4-tetrahydro-1-methyl-7-quinolinyl]-1,1,1-trifluoromethanesulfonamidato-kN]-
|
494197-74-9
|
C34H28F6N16NiO4S2
|
|
2-(Di-t-butylphosphinoMethyl)pyridine
|
494199-72-3
|
C14H24NP
|
|
(Z)-2-(benzo[d]oxazol-2-yl)-1-(p-tolyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
|
494200-39-4
|
C26H23NO5
|
|
(2Z)-2-(1,3-benzoxazol-2-yl)-3-[5-(2-chlorophenyl)furan-2-yl]-1-phenylprop-2-en-1-one
|
494200-44-1
|
C26H16ClNO3
|
|
(2Z)-2-(1,3-benzoxazol-2-yl)-3-(3-bromophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
|
494200-51-0
|
C23H16BrNO3
|
|
(2Z)-2-(1,3-benzoxazol-2-yl)-1-[4-(propan-2-yloxy)phenyl]-3-(pyridin-3-yl)prop-2-en-1-one
|
494200-60-1
|
C24H20N2O3
|
|
N-(3,4-dimethylphenyl)-5-(1-isopropyl-1H-tetrazol-5-yl)-2-methoxybenzenesulfonamide
|
494200-76-9
|
C19H23N5O3S
|
|
(Z)-2-(benzo[d]oxazol-2-yl)-3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
|
494200-87-2
|
C25H21NO5
|
|
(Z)-2-(benzo[d]oxazol-2-yl)-1-(4-methoxyphenyl)-3-(5-methylfuran-2-yl)prop-2-en-1-one
|
494200-92-9
|
C22H17NO4
|
|
2-((4-allyl-5-(3-chlorobenzo[b]thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid
|
494201-03-5
|
C15H12ClN3O2S2
|
|
4(1H)-Pyrimidinone, 2-amino-6-(methoxymethyl)- (9CI)
|
494202-82-3
|
C6H9N3O2
|
|
3-Chloro-3'-nitrobenzophenone
|
494203-12-2
|
C13H8ClNO3
|
|
Benzonitrile, 2-(methoxymethoxy)- (9CI)
|
494209-23-3
|
C9H9NO2
|
|
Cyclopentanecarboxamide, 2-amino-, (1R,2R)-rel- (9CI)
|
494209-32-4
|
C6H12N2O
|
|
Ethanone, 2-diazo-1-(5-thiazolyl)-
|
494210-16-1
|
C5H3N3OS
|
|
7-Oxabicyclo[2.2.1]heptan-2-ol,4-methyl-1-(1-methylethyl)-,(1S,2S,4S)-(9CI)
|
494210-18-3
|
C10H18O2
|
|
2H-Thiopyran-4-carboxaldehyde, tetrahydro-, 1,1-dioxide
|
494210-61-6
|
C6H10O3S
|
|
Bicyclo[3.1.0]hexane-3-carboxaldehyde, 6,6-difluoro- (9CI)
|
494210-62-7
|
C7H8F2O
|
|
Amino-6,6-difluoro-bicyclo[3.1.0]hexane-3-acetic acid
|
494210-64-9
|
C8H11F2NO2
|
|
a-(Fmoc-amino)-tetrahydropyran-4-propanoic acid
|
494210-66-1
|
C23H25NO5
|
|
2-N-Boc-Amino-3-(4-tetrahydrothiopyranyl)propionic acid
|
494210-67-2
|
C13H23NO4S
|
|
2-N-Boc-amino-3[4-(1,1-dioxo-tetrahydro-thiopyranyl)!propionic acid, 95
|
494210-69-4
|
C13H23NO6S
|
|
tert-Butoxycarbonylamino-piperidin-4-yl-acetic acid
|
494210-73-0
|
C12H22N2O4
|
|
Furan, 2,5-diethoxy-3-(ethylthio)tetrahydro- (9CI)
|
494211-24-4
|
C10H20O3S
|
|
3-Dehydroquinic acid potassium salt, (1R,3R,4S)-1,3,4-Trihydroxy-5-oxocyclohexanecarboxylic acid potassium salt
|
494211-79-9
|
C7H9O6.K
|
|
Cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-(hydroxyimino)-, (1S,3R,4R,5E)- (9CI)
|
494211-80-2
|
C7H11NO6
|
|
Cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-(hydroxyimino)-, methyl ester, (1S,3R,4R,5E)- (9CI)
|
494211-81-3
|
C8H13NO6
|
|
2,5-dibromo-3-(6-bromohexyl)thiophene
|
494212-94-1
|
C10H13Br3S
|
|
(1-Ethyl-3-methyl-1H-pyrazol-4-yl)-methanol
|
494214-30-1
|
C7H12N2O
|
|
(1-Ethyl-5-methyl-1H-pyrazol-4-yl)-methanol
|
494214-31-2
|
C7H12N2O
|
|
5(1H)-Indolizinone, hexahydro-8-hydroxy-, (8R,8aS)- (9CI)
|
494225-05-7
|
C8H13NO2
|
|
5,8-Indolizinedione,hexahydro-,(8aS)-(9CI)
|
494225-07-9
|
C8H11NO2
|
|
2-Pyrrolidinone, 4-acetyl-5,5-dimethyl- (9CI)
|
494225-22-8
|
C8H13NO2
|
|
(R)-1-[(R)-2-[2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]phenyl]ferrocenyl]-ethylbis[3,5-bis(trifluoromethyl)phenyl]phosphine
|
494227-30-4
|
C52H44F12FeO2P210*
|
|
(R)-1-[(R)-2-[2-(Diphenylphosphino)phenyl]ferrocenyl]ethyldi(3,5-xylyl)phosphine
|
494227-31-5
|
C46H44FeP210*
|
|
(R)-1-[(R)-2-[2-(Dicyclohexylphosphino)phenyl]ferrocenyl]ethylbis[3,5-bis(trifluoromethyl)phenyl]phosphine
|
494227-32-6
|
C46H44F12FeP210*
|
|
(R)-1-[(R)-2-[2-[Di(3,5-xylyl)phosphino]phenyl]ferrocenyl]ethyldi(3,5-xylyl)phosphine
|
494227-33-7
|
C50H52FeP210*
|
|
(alphaR,alphaR)-1,1'-Bis[alpha-(dimethylamino)benzyl]-(S,S)-2,2'-bis(dicyclohexylphosphino)ferrocene
|
494227-35-9
|
C52H72FeN2P2
|
|
(alphaR,alphaR)-1,1'-Bis[alpha-(dimethylamino)benzyl]-(S,S)-,2'-bis[bis[3,5-bis(trifluoromethyl)phenyl]phosphino]ferrocene
|
494227-36-0
|
C60H42F24FeN2P210*
|
|
(alphaR,alphaR)-1,1'-Bis[alpha-(dimethylamino)benzyl]-(S,S)-2,2'-bis[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocene
|
494227-37-1
|
C64H74FeN2O4P210*
|
|
(S)-1-Dicyclohexylphosphino-2-[(R)--(dimethylamino)-2-(dicyclohexylphosph
|
494227-38-2
|
C43H63FeNP2
|
|
Carbamic acid, [4-amino-1-(aminocarbonyl)butyl]-, methyl ester (9CI)
|
494227-55-3
|
C7H15N3O3
|
|
Pyridine, 2,3-dihydro-2,5-dimethoxy-6-(methylthio)- (9CI)
|
494747-08-9
|
C8H13NO2S
|
|
6-Bromo-2-methyloxazolo[4,5-b]pyridine
|
494747-09-0
|
C7H5BrN2O
|
|
2-(3,5-Dimethyl-4-nitro-pyrazol-1-yl)-propionic acid ethyl ester
|
494747-21-6
|
C10H15N3O4
|
|
3-(4-Nitro-pyrazol-1-yl)-propionic acid methyl ester
|
494747-22-7
|
C7H9N3O4
|